Called the Galleri test, it works by detecting traces of cancer-linked DNA circulating in the blood
A new blood test for the over-50s which aspires to detect the presence of around 50 forms of cancer before symptoms even appear has begun to be tested on patients by the British NHS.
The first mass trial of US company Grail's new test involves 140 people.000 volunteers, with some hundreds of them already referred for testing due to early results.
Although there are no definitive conclusions yet about the degree of effectiveness of the test, British researchers are confident of the "huge" potential that is opening up in the field of early diagnosis.
As the Daily Mail reports, the hope is that the test will be able to prevent around 16.000 deaths a year in Britain, or 10% of the cancer deaths that occur each year in the country.
Professor Peter Sasieni, one of the three lead investigators of the clinical trial of the test from King's College London, noted among other things that if the new method of early diagnosis proves successful, then in the long term, in addition to the benefit to patients, there will be an economic benefit to the NHS, as it will reduce the need for the costly chemotherapy procedure and expensive anti-cancer drugs.
If found effective, the blood test is expected to begin
to be widely used by the NHS perhaps as early as 2024.[/B]
Called the Galleri test, it works by detecting traces of cancer-linked DNA circulating in the blood.
Of the total 167,000 annual cancer deaths in the UK, most are due to lung cancer (34,771). They are followed as the most deadly forms of the disease by colon cancer (16,807), prostate cancer (12,039), breast cancer (11,500) and pancreatic cancer (9,557).
Source: CNA
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source